Hubert Thomassen is the new CEO of Ventinova Medical

Eindhoven, 09 March 2022 – The supervisory board of Ventinova Medical is pleased to announce that Hubert Thomassen is the new CEO. Ventinova Medical is a MedTech company that has introduced an innovative and patented ventilation technique that redefines patient ventilation: FCV^®.

 Hubert Thomassen brings 35 years of Executive Management experience in Medical Devices. Since 2019 he has been directly involved in the commercialization of Ventinova products. Hubert succeeds founder Dirk van Asseldonk, who has decided to step out as CEO to take up new challenges. Dirk is acknowledged for his expertise and retains involved as advisor to the management team.

“We thank Dirk for 14 years of strong commitment to boosting Ventinova’s ventilation business. In Hubert we have found a great successor, who is perfectly positioned to propel Ventinova into a new phase of growth” Tim Irish – Chairman Supervisory Board

Hubert Thomassen: “I am truly proud to join this company and very eager to progress the use of our superior ventilation technology to a growing number of therapeutic applications on a global scale. Also, it is nice to be back in my home town Eindhoven, after an extensive international carrier”

 About Ventinova Medical

Ventinova Medical, founded in 2013, aims to redefine patient ventilation. Ventinova’s products currently marketed are mechanical ventilator Evone^®, the ultrathin ventilation tube Tritube^®, the manual, disposable emergency ventilator Ventrain^® and transtracheal catheter Cricath^®. The products are now being sold in Ventinova’s direct markets the Netherlands, Belgium and Germany and as well as a growing network of  distributors covering more than 20 other European and Middle East countries. Ventinova Medical has a strong patent portfolio, a broad network of Key Opinion Leaders in Europe, the Middle East and the USA and a disruptive technology with solid clinical evidence. With Ventrain already FDA approved, FDA submission of Evone is in progress.